LifeMD is a fast-growing, profitable telehealth company with strong partnerships. Click here to read why LFMD stock is a Buy.

LifeMD does accept some insurance plans for medication, though this varies depending on the provider and medication. The LifeMD Weight Management Program does not include the cost of medication.

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States.

A unique business structure gives LifeMD access to the growing GLP-1 marketplace that can help boost the heavily shorted stock price. Read an analysis of LFMD here.

HIMS and LFMD are surging in the telehealth race, but which one has stronger earnings growth and expansion momentum? Let's see.

LifeMD announces a cash dividend of $0.5546875 per share for its 8.875% Series A Preferred Stock, payable July 15, 2025.

Hims & Hers is a consumer-first platform transforming the way customers fulfill their health and wellness needs, while LifeMD is a direct-to-patient telehealth company that provides a cost-effective ...

Virtual healthcare services, or telehealth, are rapidly becoming a standard of care in the expanding digital healthcare space ...

LifeMD is diversifying across new service lines including Hormone Replacement Therapy, mental health, and women’s health, according to BTIG’s analysis.

Novo Nordisk confirmed that its partnerships with LifeMD and Ro will continue as the pharmaceutical giant expands patient access to its weight-loss drug Wegovy.

In addition, LifeMD launched a $299 weight management bundle, including Wegovy® and a virtual weight loss program, in collaboration with Novo Nordisk. Analyst firms such as Cantor Fitzgerald and BTIG ...